LGC has published the 'Pharmaceutical Reference Substances and Impurities 2009' catalogue.
In addition to its own products, the LGC Standards catalogue covers the latest listings from a range of suppliers, including all the major pharmacopoeia, making it suitable for anyone involved in pharmaceutical analysis.
The catalogue includes a comprehensive range of LGC Standards, pharmaceutical impurities and more than 2400 impurity standards.
Accurate detection of impurities in a pharmaceutical substance is important, as they can significantly change the effects and side effects of a drug.
The European Pharmacopoeia and the United States Pharmacopeia emphasise that it is not sufficient to test impurities according to the monograph, but to perform additional tests whenever there is evidence that the monograph cannot sufficiently control the impurities present.
LGC Standards is embracing internationally recognised ISO Guide 34 protocols with a future focus on certified reference materials and primary standards, in addition to the current range.
During 2009, customers will begin to see reference standards for drug substances and major impurities converted to Certified Reference Materials (CRMs).
This change will enhance the quality of customers' analytical processes, as certificates of analysis will feature more detailed information about the analytical characterisation of the substance.
The catalogue also includes the World Health Organisation (WHO) antibiotic standards, essential in the standardisation and quality control of antibiotic material and pharmaceutical products.
